The Clinical Research Coordinating Office (CRCO) serves UW Carbone Cancer Center (UWCCC) members and researchers by providing administrative infrastructure and oversight of all clinical and translational research conducted at the UWCCC, with the principal goal to ensure scientifically sound and high quality clinical research across the UWCCC. The CRCO is composed of experienced research staff that provides support for the strategic aspects of identifying, prioritizing and conducting clinical research activities at UWCCC and UW Affiliate Site Network (Wisconsin Oncology Network). These functions are accomplished through its interactions with key research entities (IRB, Pharmaceutical Research Center and Disease Oriented Working Groups/Clinical Research Groups) and the clinical care entities (Clinical Research Unit, UW Hospital and Clinics). The CRCO also provides essential administrative support to UWCCC clinical research committees such as the Protocol Review and Monitoring Committee and Data Safety and Monitoring Committee. The CRCO staff members provide the following services;? Protocol review and implementation, which includes protocol identification, protocol review, protocol activation, study closure, and database management ? Human subjects committee coordination and oversight, which includes protocol activation and continuing annual review tracking ? Centralized patient tracking ? Research policy development, coordination and implementation, which is developed and implemented through the Program Manager Committee and the development of standard operating procedures ? Training coordination and implementation ? Education and corrective action facilitation ? Administrative oversight ? Protocol development and patient case report forms development for Investigator Initiated Trials ? Data abstraction and final report tables for Investigator Initiated Trials The Faculty Leader for the CRCO is the Associate Director for Clinical Research (Brad Kahl, M.D.), who has extensive experience in the conduct and oversight of clinical research.

Public Health Relevance

The Clinical Research Coordinating Office (CRCO) serves UW Carbone Cancer Center (UWCCC) members and researchers by providing administrative infrastructure and oversight of all clinical and translational research conducted at the UWCCC, with the principal goal to ensure scientifically sound and high quality clinical research across the UWCCC. The CRCO is composed of experienced research staff that provides support for the strategic aspects of identifying, prioritizing and conducting clinical research activities at UWCCC and UW Affiliate Site Network (Wisconsin Oncology Network).

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA014520-40
Application #
8762775
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2014-04-01
Budget End
2015-03-31
Support Year
40
Fiscal Year
2014
Total Cost
$168,602
Indirect Cost
$59,442
Name
University of Wisconsin Madison
Department
Type
DUNS #
161202122
City
Madison
State
WI
Country
United States
Zip Code
53715
Liu, Bai; Jones, Monica; Kong, Lin et al. (2018) Evaluation of the biological activities of the IL-15 superagonist complex, ALT-803, following intravenous versus subcutaneous administration in murine models. Cytokine 107:105-112
Yu, Deyang; Yang, Shany E; Miller, Blake R et al. (2018) Short-term methionine deprivation improves metabolic health via sexually dimorphic, mTORC1-independent mechanisms. FASEB J 32:3471-3482
Carroll, Molly J; Fogg, Kaitlin C; Patel, Harin A et al. (2018) Alternatively-Activated Macrophages Upregulate Mesothelial Expression of P-Selectin to Enhance Adhesion of Ovarian Cancer Cells. Cancer Res 78:3560-3573
Ehlerding, Emily B; Grodzinski, Piotr; Cai, Weibo et al. (2018) Big Potential from Small Agents: Nanoparticles for Imaging-Based Companion Diagnostics. ACS Nano 12:2106-2121
Park, Linda; Schwei, R J; Xiong, P et al. (2018) Addressing Cultural Determinants of Health for Latino and Hmong Patients with Limited English Proficiency: Practical Strategies to Reduce Health Disparities. J Racial Ethn Health Disparities 5:536-544
Ehlerding, Emily B; Lan, Xiaoli; Cai, Weibo (2018) ""Albumin Hitchhiking"" with an Evans Blue Analog for Cancer Theranostics. Theranostics 8:812-814
Morris, Zachary S; Guy, Emily I; Werner, Lauryn R et al. (2018) Tumor-Specific Inhibition of In Situ Vaccination by Distant Untreated Tumor Sites. Cancer Immunol Res 6:825-834
Yu, Bo; Goel, Shreya; Ni, Dalong et al. (2018) Reassembly of 89 Zr-Labeled Cancer Cell Membranes into Multicompartment Membrane-Derived Liposomes for PET-Trackable Tumor-Targeted Theranostics. Adv Mater 30:e1704934
England, Christopher G; Jiang, Dawei; Ehlerding, Emily B et al. (2018) 89Zr-labeled nivolumab for imaging of T-cell infiltration in a humanized murine model of lung cancer. Eur J Nucl Med Mol Imaging 45:110-120
Rutter, Carolyn M; Kim, Jane J; Meester, Reinier G S et al. (2018) Effect of Time to Diagnostic Testing for Breast, Cervical, and Colorectal Cancer Screening Abnormalities on Screening Efficacy: A Modeling Study. Cancer Epidemiol Biomarkers Prev 27:158-164

Showing the most recent 10 out of 1528 publications